Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening for prostate cancer.

S R Gambert1

  • 1Johns Hopkins University School of Medicine, Baltimore, MD 21215, USA.

International Urology and Nephrology
|July 3, 2002
PubMed
Summary
This summary is machine-generated.

Prostate cancer screening methods are debated, with ongoing research for better early detection. Newer techniques aim to improve accuracy and reduce false positives for effective screening protection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prostate cancer. When to offer screening in the primary care setting.

Geriatrics·2001
Same author

The impact of early clinical training in medical education: a multi-institutional assessment.

Academic medicine : journal of the Association of American Medical Colleges·1999
Same author

Intracellular calcium, DNase activity and myocyte apoptosis in aging Fischer 344 rats.

Journal of molecular and cellular cardiology·1998
Same author

Proliferating cell nuclear antigen (PCNA), DNA synthesis and mitosis in myocytes following cardiac transplantation in man.

Journal of molecular and cellular cardiology·1997
Same author

Alcohol abuse: medical effects of heavy drinking in late life.

Geriatrics·1997
Same author

Is it Alzheimer's disease?

Postgraduate medicine·1997
Same journal

Does WHO/ISUP grade IV histology provide prognostic insight in chromophobe renal cell carcinoma?

International urology and nephrology·2026
Same journal

Age-stratified association between blood pressure and clinical outcomes in maintenance hemodialysis patients.

International urology and nephrology·2026
Same journal

Management and implementation of intermittent catheterisation in neurogenic lower urinary tract dysfunction: a clinical practice guideline in Germany - update 3.0.

International urology and nephrology·2026
Same journal

Interpreting short-term eGFR improvement with telitacicept in IgA nephropathy.

International urology and nephrology·2026
Same journal

Medical expulsive therapies for ureteric stones: an umbrella review of network meta-analyses with novel evidence grading.

International urology and nephrology·2026
Same journal

Associations between PM2.5 exposure and upper tract urothelial carcinoma in a taiwanese case-control study.

International urology and nephrology·2026
See all related articles

Area of Science:

  • Oncology
  • Urology
  • Public Health

Background:

  • Prostate cancer is the second most common cancer in men.
  • High incidence rates observed in men aged 65 and older (635 per 100,000).
  • Existing prostate cancer detection methods face ongoing debate regarding optimal use and benefits.

Purpose of the Study:

  • To address the ongoing debate surrounding the best methods for early prostate cancer detection.
  • To explore the controversies regarding screening benefits and target populations.
  • To highlight the development of novel detection techniques.

Main Methods:

  • Review of current prostate cancer detection strategies.
  • Analysis of existing literature on screening efficacy and controversies.

Related Experiment Videos

  • Discussion of emerging technologies in prostate cancer diagnostics.

    • Main Results:

    • Significant debate exists regarding optimal prostate cancer screening protocols.
    • Varied opinions on the proven benefits of early cancer detection.
    • Development of new methods is underway to enhance screening accuracy.

    Conclusions:

    • Further research is needed to establish definitive prostate cancer screening guidelines.
    • Newer detection technologies show promise in reducing false positives.
    • Balancing screening adequacy with accuracy remains a key challenge in prostate cancer management.